Compare Motorola Solutions Inc (MSI) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Motorola Solutions Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Motorola Solutions Inc trades at $444.18 (market cap $74.00B), while State Street SPDR S&P Biotech ETF trades at $153.75 (market cap $10.11B). The key difference: Motorola Solutions Inc is far larger — about 7.3× State Street SPDR S&P Biotech ETF's market cap, and Motorola Solutions Inc pays a 1.08% dividend while State Street SPDR S&P Biotech ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Motorola Solutions Inc for 100 Days and State Street SPDR S&P Biotech ETF for 38 Days on average.
| MSI | XBI | |
|---|---|---|
Market Cap | $74.00B | $10.11B |
Volume | 722,147 | 12,903,266 |
Sector | Technology | Broad Market / Factor |
52-Week High | $491.24 | $169.55 |
52-Week Low | $363.83 | $104.99 |
Typical Hold Time | 100 Days | 38 Days |
Enterprise Value | $82.90B | — |
Dividend Yield | 1.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MSI (Motorola Solutions) trades at $447.12, down 0.3% on the day, with a bearish technical signal but strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $4.41 surpassing the $3.85 estimate. Revenue grew to $11.68B in 2025, and net income margin improved to 17.44%. Recent news highlights expansion in defense and public safety contracts, including a $139 million Louisiana deal and a $1.5B acquisition of D-Fend Solutions.
Outlook remains positive driven by a record $15.6B backlog and strategic acquisitions, though high valuation ratios (P/E 35.23) and significant investing cash outflows pose risks. Analyst consensus is bullish with a $525.86 price target, implying 17.6% upside, but investors should monitor debt levels and integration of recent purchases.
XBI trades at $149.29, down 0.63% on the day, with technical indicators showing a bearish bias despite oversold RSI conditions. The ETF faces mixed sentiment with 100% hold ratings from analysts but positive catalysts from biotech breakthroughs. Recent news highlights XBI's 76% rally over the past year and ongoing M&A activity driving sector optimism.
Outlook remains cautiously optimistic with potential upside from cancer vaccine developments and sector consolidation, though high volatility and expense ratios relative to broader healthcare ETFs present risks. The ETF's modified equal-weight structure offers diversified exposure to 150+ biotech names, benefiting from improved capital access and clinical trial catalysts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →About State Street SPDR S&P Biotech ETF
XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →
